Sterimedix Limited

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Sterimedix Limited - overview

Established

1989

Location

London, England, UK

Primary Industry

Medical Devices & Equipment

About

Sterimedix Limited manufactures single-use ophthalmic medical devices aimed at enhancing surgical outcomes in eye care, offering precision-engineered products for various ocular procedures. Founded in 1989, Sterimedix specializes in the production of ophthalmic medical devices, particularly focusing on single-use products. The company operates from its headquarters in the United Kingdom and has expanded its market reach to over 60 countries, including key markets in Europe, North America, and Asia. While there are no known pivots or shifts in business strategy, Sterimedix has maintained its commitment to quality and precision in eye care.


The founder's background and previous ventures are not publicly available. Sterimedix specializes in the manufacturing of single-use ophthalmic medical devices, focusing on precision-engineered products that enhance surgical outcomes in eye care. The company’s core offerings include ophthalmic cannulas, Irrigation Aspiration Handpieces, and aesthetic cannulas, which assist surgeons in various eye procedures, such as cataract surgery and ocular interventions. These products meet stringent safety and efficacy standards required in the medical field, providing reliable tools that help restore or protect patients’ vision.


Sterimedix caters to a global clientele, serving healthcare providers, hospitals, and surgical centers across more than 60 countries, including key markets in Europe, North America, and Asia. Sterimedix operates on a business-to-business model, generating revenue primarily through direct sales to healthcare institutions and distributors within the ophthalmic sector. The pricing structure reflects the high-quality standards of their products, with clients placing bulk orders for devices like ophthalmic cannulas and handpieces to ensure a consistent supply for surgical procedures. This approach facilitates streamlined inventory management for healthcare providers and strengthens relationships with distributors and healthcare professionals who rely on Sterimedix products for effective patient care.


Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Devices & Equipment, Medical Supplies

Website

www.sterimedix.com

Verticals

Manufacturing

Total Amount Raised

Subscriber access only

Sterimedix Limited - timeline of key events

Blurred Background

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

Sterimedix Limited - financials

Fiscal Year EndedDec 31, 2019Dec 31, 2020Dec 31, 2021Dec 31, 2022
Revenue (USD)9,539,235---
% Revenue Growth (YoY)----
EBITDA (USD)3,525,690---
Operating Income (USD)3,356,489---
Operating Margin35.2%---
% EBITDA Margin37.0%---
NET Income (USD)2,713,043---
% Net Margin28.4%---

Sterimedix Limited - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.